Today Enzymatica has published the prospectus for the new rights issue with pre-emptive rights for the company’s shareholders. To read more about the subscription of shares – see under “Investors” and “New rights issue April 2016” at the company’s web site. Here you will find a brief description of the rights issue (short version of the prospectus) and how one subscribes for shares and application form. The entire prospectus in Swedish is also available.
For more information, please contact:
Carl-Johan Wachtmeister, deputy communication officer Enzymatica
Tel: 0701-88 50 21 | E-post: firstname.lastname@example.org
The information in this News does not contain or constitute an offer to acquire, subscribe or otherwise trade in shares, subscription rights or other securities in Enzymatica AB (publ). Any invitation to the persons concerned to subscribe for shares in Enzymatica AB (publ) will only be made through the prospectus that Enzymatica AB (publ) estimates to publish on or about 20 April 2016.